Binding of human secretory leukocyte protease inhibitor in uterine cervical mucus to immunoglobulins: Pathophysiology in immunologic infertility and local immune defense

Fertility and Sterility

Volumn 71, Issue 6, 1999, Pages 1108-1114

  Kamada, Masaharu ^a,b   Maegawa, Masahiko ^a   Aono, Toshihiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Gima Clinic   (Japan)

Author keywords

Antisperm antibody; Cervical mucus; Immunoglobulin; Local immunity; Secretory leukocyte protease inhibitor

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; MOLECULAR DYNAMICS; MUCOSAL IMMUNITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; UTERINE CERVIX MUCUS;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CERVIX MUCUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; INFERTILITY, FEMALE; MOLECULAR SEQUENCE DATA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SERINE PROTEINASE INHIBITORS;

EID: 0033151733     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00142-9     Document Type: Article

References (34)

1. Koyama K., Hasegawa A., Isojima S. Effect of anti-sperm antibody on the in vitro development of rat embryo. Gamete Res. 10:1984;143-152.
2. Shulman S. Immunological reactions and infertility. Kurpisz M., Fernandez N., Immunology of human reproduction. 1995;53-78 BIOS Scientific Publishers, Oxford.
3. Kamada M., Daito T., Hasebe H., Irahara M., Yamano S., Mori T. Blocking of human fertilization in vitro by sera with sperm-immobilizing antibodies. Am J Obstet Gynecol. 153:1985;328-331.
4. Kamada M., Yamano S., Nakagawa K., Maegawa M., Aono T. Semen analysis and antisperm antibodies. Arch Androl. 40:1998;85-96.
5. Bandoh R., Yamano S., Kamada M., Daitoh T., Aono T. Effect of sperm-immobilizing antibodies on the acrosome reaction of human spermatozoa. Fertil Steril. 57:1992;387-392.
6. Daitoh T., Kamada M., Yamano S., Murayama S., Kobayashi T., Maegawa M., et al. High implantation rate and consequently high pregnancy rate by in vitro fertilization-embryo transfer treatment in infertile women with antisperm antibody. Fertil Steril. 63:1995;87-91.
7. Fjällbrant B. Interrelation between high levels of sperm antibodies, reduced penetration of cervical mucus by spermatozoa, and sterility in men. Acta Obstet Gynecol Scand. 47:1968;102-118.
8. Schumacher G.F.B. Immunology of spermatozoa and cervical mucus. Hum Reprod. 3:1988;289-300.
9. Moghissi K.S., Sacco A.G., Borin K. Immunologic infertility. I. Cervical mucus antibodies and post-coital test. Am J Obstet Gynecol. 136:1980;941-950.
10. Eggert-Kruse W., Bochem-Hellwig S., Doll A., Rohr G., Tilgen W., Runnebaum B. Antisperm antibodies in cervical mucus in an unselected subfertile population. Hum Reprod. 8:1993;1025-1031.
11. Kremer J., Jager S. The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod. 7:1992;781-784.
12. Isojima S., Koyama K., Ikuma K., Kou S. Influence of weak antisperm antibody on sperm penetration in women's cervical mucus. Bratanov K., Vulchanov V.H., Dikov V., Somlev V., Kozhouharova L., Immunology of reproduction. 1978;341-346 Publishing House of the Bulgarian Academy of Science, Sofia.
13. Jager S., Kremer J., Kuiken J., Mulder I. The significance of the Fc part of antispermatozoal antibodies for the shaking phenomenon in the sperm-cervical mucus contact test. Fertil Steril. 36:1981;792-797.
14. Bronson R.A., Cooper G.W., Rosenfeld D.L., Gilbert J.V., Plaut A.G. The effect of an IgA1 protease on immunoglobulins bound to the sperm surface and cervical mucus penetrating ability. Fertil Steril. 47:1987;985-991.
15. Thompson R.C., Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA. 83:1986;6692-6696.
16. Fink E., Nettelbeck R., Fritz H. Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. Biol Chem Hoppe Seyler. 361:1986;567-571.
17. Zhang Y., DeWitt D.L., McNeely T.B., Wahl S.M., Wahl L.M. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest. 99:1997;894-900.
18. Jin F., Nathan C., Radzioch D. Secretory leukocyte protease inhibitor a macrophage product induced by and antagonistic to bacterial lipopolysaccharide . Cell. 88:1997;417-426.
19. Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol. 36:1997;23-50.
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Heinzel R., Appelhans H., Gassen G., Seemuller U., Machleidt W., Fritz H., et al. Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur J Biochem. 160:1986;61-67.
22. Malmqvist M. Biospecific interaction analysis using biosensor technology. Nature. 361:1993;186-187.
23. Wang A.C. The structure of immunoglobulins. Fudenburg H.H., Stites D.P., Caldwell J.L., Wells L.V., Basic and clinical immunology. 1976;15-31 Lange Medical Publications, Maruzen Company, Tokyo.
24. Van-Seuningen I., Davril M., Mayem A. Evidence for the tight binding of human mucus proteinase inhibitor to highly glycosylated macromolecules in sputum. Biol Chem Hoppe Seyler. 370:1989;749-755.
25. Kamada M., Maeda N., Maegawa M., Mori H., Yamamoto S., Aono T., et al. Detection of immunoglobulin binding factor by enzyme-linked immunosorbent assay using two monoclonal antibodies. Biochem Mol Biol Int. 34:1994;837-844.
26. Mori H., Kamada M., Maegawa M., Yamamoto S., Aono T., Futaki S., et al. Enzymatic activation of immunoglobulin binding factor in female reproductive tract. Biochem Biophys Res Commun. 246:1998;409-413.
27. Fritz H. Human mucus proteinase inhibitor (human MPI). Biol Chem Hoppe Seyler. 369:1988;79-82.
28. Franken C., Meijer C.J.L.M., Dijkman J.H. Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem. 37:1989;493-498.
29. Birrer P., McElvaney N.G., Gillissen A., Hoyt R.F., Bloedow D.C., Hubbard R.C., et al. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense. J Appl Physiol. 73:1992;317-323.
30. Aminitani R., Wilson R., Rutman A., Read R., Ward C., Burnett D., et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory endothelium. Am J Respir Cell Mol Biol. 4:1991;26-32.
31. Hiemstra P.S., Maassen R.J., Stolk J., Heinzel-Wieland R., Steffens G.J., Dijkman J.H. Antibacterial activity of antileukoprotease. Infect Immun. 64:1996;4520-4524.
32. McNeely T.B., Dealy M., Dripps D.J., Orenstein J.M., Eisenberg S.P., Wahl S.M. Secretory leukocyte protease inhibitor a human saliva proteinexhibiting anti-human immunodeficiency virus activity in vitro . J Clin Invest. 96:1995;456-464.
33. Beppu Y., Imamura Y., Tashiro M., Towatari T., Ariga H., Kido H. Human mucus protease inhibitor in airway fluid is a potential defensive compound against infection with influenza A and Sendai viruses. J Biochem (Tokyo). 121:1997;309-316.
34. McElvaney N.G., Hubbard R.C., Barrer P., Chernick M.S., Caplan D.B., Frank M.M., et al. Aerosol alpha1-antitrypsin treatment for cystic fibrosis. Lancet. 337:1991;392-394.